Janssen Scientific Affairs, Llc

This program offers an experimental cell therapy called cilta-cel to people with multiple myeloma who have run out of standard options. It uses a version of the treatment that doesn't meet commercial quality standards but may still help. Participants must be seriously ill and hav…

This study looks at the long-term safety of the drug ustekinumab compared to other biologic treatments in adults with Crohn's disease or ulcerative colitis. Researchers will use health records from the Department of Defense to track rates of cancer, serious infections, and other …